| scholarly article | Q13442814 |
| P2093 | author name string | Graham JM | |
| Griffiths PD | |||
| Grünewald RA | |||
| Hoggard N | |||
| Paley MN | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Parkinson's disease | Q11085 |
| P304 | page(s) | 2423-2431 | |
| P577 | publication date | 2000-12-01 | |
| P1433 | published in | Brain | Q897386 |
| P1476 | title | Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. | |
| P478 | volume | 123 Pt 12 |
| Q35918844 | A comparison of MRI tissue relaxometry and ROI methods used to determine regional brain iron concentrations in restless legs syndrome |
| Q30495444 | A review of structural magnetic resonance neuroimaging |
| Q30835548 | A review of the use of magnetic resonance imaging in Parkinson's disease |
| Q46120658 | Acute and chronic metal exposure impairs locomotion activity in Drosophila melanogaster: a model to study Parkinsonism. |
| Q37947718 | Advances in imaging in Parkinson's disease. |
| Q35649302 | Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeutics |
| Q31142064 | Brain imaging and networks in restless legs syndrome |
| Q45404273 | Brain iron MRI: a biomarker for amyotrophic lateral sclerosis. |
| Q52093058 | Brain iron concentrations in regions of interest and relation with serum iron levels in Parkinson disease. |
| Q37193370 | Brain iron deficiency in idiopathic restless legs syndrome measured by quantitative magnetic susceptibility at 7 tesla |
| Q48683675 | Brain iron deposition fingerprints in Parkinson's disease and progressive supranuclear palsy |
| Q50425686 | Brain structure and function in patients after metal-on-metal hip resurfacing |
| Q36234784 | Caveosomal oxidative stress causes Src-p21ras activation and lysine 63 TRAF6 protein polyubiquitination in iron-induced M1 hepatic macrophage activation |
| Q50553843 | Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson’s disease |
| Q41350914 | Determination of brain iron content in patients with Parkinson's disease using magnetic susceptibility imaging |
| Q33652092 | Diagnosis of Parkinson’s Disease—Transcranial Sonography in Relation to MRI |
| Q38152514 | Differences between conventional and nonconventional MRI techniques in Parkinson's disease |
| Q92309534 | Differentiating Parkinson's disease motor subtypes using automated volume-based morphometry incorporating white matter and deep gray nuclear lesion load |
| Q48841126 | Differentiation of typical and atypical Parkinson syndromes by quantitative MR imaging. |
| Q53428460 | Direct visualization of Parkinson's disease by in vivo human brain imaging using 7.0T magnetic resonance imaging. |
| Q34372099 | Does structural neuroimaging reveal a disturbance of iron metabolism in Parkinson's disease? Implications from MRI and TCS studies |
| Q37068758 | Effects of hemochromatosis and transferrin gene mutations on peripheral iron dyshomeostasis in mild cognitive impairment and Alzheimer's and Parkinson's diseases. |
| Q44071657 | Estradiol protects dopaminergic neurons in a MPP+Parkinson's disease model. |
| Q94453353 | Evaluation of abnormal iron distribution in specific regions in the brains of patients with Parkinson's disease using quantitative susceptibility mapping and R2* mapping |
| Q64081176 | Evaluation of iron deposition in brain basal ganglia of patients with Parkinson's disease using quantitative susceptibility mapping |
| Q48159358 | High nigral iron deposition in LRRK2 and Parkin mutation carriers using R2* relaxometry |
| Q48851886 | High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease |
| Q36434577 | Imaging nigral pathology and clinical progression in Parkinson's disease |
| Q48302457 | Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in Clinically Isolated Syndrome |
| Q35202338 | Insulin resistance impairs nigrostriatal dopamine function |
| Q82029441 | Iron as a trigger of neurodegeneration in Parkinson's disease |
| Q40195592 | Iron causes interactions of TAK1, p21ras, and phosphatidylinositol 3-kinase in caveolae to activate IkappaB kinase in hepatic macrophages |
| Q35024676 | Iron homeostasis and the inflammatory response |
| Q31117154 | Iron in chronic brain disorders: imaging and neurotherapeutic implications |
| Q30457611 | Is R2* a new MRI biomarker for the progression of Parkinson's disease? A longitudinal follow-up |
| Q36902028 | Lateral Asymmetry and Spatial Difference of Iron Deposition in the Substantia Nigra of Patients with Parkinson Disease Measured with Quantitative Susceptibility Mapping |
| Q47926107 | MR image texture in Parkinson's disease: a longitudinal study. |
| Q35848072 | MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients |
| Q37370641 | MRI estimates of brain iron concentration in normal aging: comparison of field-dependent (FDRI) and phase (SWI) methods. |
| Q47376890 | MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease |
| Q58574554 | Magnetic resonance T1w/T2w ratio: A parsimonious marker for Parkinson's disease |
| Q50243985 | Magnetic resonance correlation of iron content with neuromelanin in the substantia nigra of early-stage Parkinson's disease. |
| Q33909042 | Magnetic resonance imaging assessment of excess iron in thalassemia, sickle cell disease and other iron overload diseases |
| Q50562845 | Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature. |
| Q33944366 | Magnetic resonance imaging measurement of iron overload |
| Q24040262 | Mapping track density changes in nigrostriatal and extranigral pathways in Parkinson's disease |
| Q89686131 | Maturation of the human striatal dopamine system revealed by PET and quantitative MRI |
| Q37402514 | Meta-analysis of brain iron levels of Parkinson's disease patients determined by postmortem and MRI measurements |
| Q38387716 | Metabolic reprogramming and cell fate regulation in alcoholic liver disease |
| Q48393606 | Motor associations of iron accumulation in deep grey matter nuclei in Parkinson's disease: a cross-sectional study of iron-related magnetic resonance imaging susceptibility |
| Q58000673 | Movement disorder due to aceruloplasminemia and incorrect diagnosis of hereditary hemochromatosis |
| Q27316725 | Multimodal MRI Evaluation of the MitoPark Mouse Model of Parkinson's Disease |
| Q37192855 | Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease |
| Q42416323 | Novel Pattern of Iron Deposition in the Fascicula Nigrale in Patients with Parkinson's Disease: A Pilot Study |
| Q41777125 | On the lorentzian versus Gaussian character of time-domain spin-echo signals from the brain as sampled by means of gradient-echoes: Implications for quantitative transverse relaxation studies |
| Q48329843 | Parkinson's disease: diagnostic potential of high-resolution phase difference enhanced MR imaging at 3 T. |
| Q37778565 | Pathophysiology of transcranial sonography signal changes in the human substantia nigra. |
| Q62083470 | Phosphorylation-dependent metal binding by α-synuclein peptide fragments |
| Q33776138 | Post translational changes to α-synuclein control iron and dopamine trafficking; a concept for neuron vulnerability in Parkinson's disease |
| Q35880556 | Potential of Diffusion Tensor Imaging and Relaxometry for the Detection of Specific Pathological Alterations in Parkinson's Disease (PD) |
| Q37631962 | Progression of Parkinson's disease in the clinical phase: potential markers |
| Q52677402 | Quantifying changes in nigrosomes using quantitative susceptibility mapping and neuromelanin imaging for the diagnosis of early-stage Parkinson's disease. |
| Q57992268 | Quantitative analysis of the SN in Parkinson's disease implementing 3D modeling at 7.0-T MRI |
| Q44649355 | Quantitative assessment of subcortical atrophy and iron content in progressive supranuclear palsy and parkinsonian variant of multiple system atrophy |
| Q33763843 | Quantitative assessment of susceptibility-weighted imaging processing methods |
| Q48330063 | Quantitative estimation of regional brain iron with magnetic resonance imaging |
| Q64862876 | Quantitative susceptibility mapping as an indicator of subcortical and limbic iron abnormality in Parkinson's disease with dementia |
| Q37650486 | Quantitative susceptibility mapping of the midbrain in Parkinson's disease |
| Q36374541 | Region-Specific Iron Measured by MRI as a Biomarker for Parkinson's Disease |
| Q50438695 | Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping |
| Q40016191 | Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping. |
| Q64786363 | Reproducible detection of nigral iron deposition in 2 Parkinson's disease cohorts |
| Q78594759 | Screening of ferritin light polypeptide 460-461InsA mutation in Parkinson's disease patients in North America |
| Q34243731 | Serum cholesterol and nigrostriatal R2* values in Parkinson's disease |
| Q48639223 | Seven-Tesla magnetic resonance images of the substantia nigra in Parkinson disease |
| Q48402405 | Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients. |
| Q64871660 | Susceptibility MRI captures nigral pathology in patients with parkinsonian syndromes |
| Q37077841 | Susceptibility-weighted MRI of extrapyramidal brain structures in Parkinsonian disorders |
| Q45324691 | The effects of prenatal methylmercury exposure on trace element and antioxidant levels in rats following 6-hydroxydopamine-induced neuronal insult |
| Q47649474 | The impact of obesity on brain iron levels and α-synuclein expression is regionally dependent |
| Q37841289 | Ultrastructural aspects of iron storage, transport and metabolism |
| Q48282777 | Usefulness of quantitative susceptibility mapping for the diagnosis of Parkinson disease |
| Q48786080 | Volume and iron content in basal ganglia and thalamus |
| Q34115501 | Voxel-based statistical analysis of fractional anisotropy and mean diffusivity in patients with unilateral temporal lobe epilepsy of unknown cause |
Search more.